Poseida Therapeutics

Poseida Therapeutics

Poseida Therapeutics

Poseida Therapeutics is translating bestinclass gene editing technologies into lifesaving treatments and developing CAR Tcell immunotherapies for cancer
Type
B2c
Founded
2014
Raised
$282.5M
Follow us
Alexa global traffic share
Twitter followers
25 Jun 2020
$110,000,000
Venture capital (Series D)
Adage Capital Management, LLC, Schonfeld Strategic Advisors, +1

Poseida Therapeutics Raises $110M in Series D Financing

FinSMEs
22 Apr 2019
$142,000,000
Venture capital (Series C)
04 Apr 2018
$30,500,000
Venture capital (Series B)

Poseida Therapeutics snags $30.5 mln Series B

PE HUB
+2